Roche Czech Republic made a net profit of CZK 252 mil with revenues of CZK 4,962 mil in 2016, up by 394% and down by 8.88%, respectively, compared to the previous year. This translates into a net margin of 5.08%.
On the operating level, EBITDA reached CZK 475 mil, up 127% compared to the previous year. Over the last five years, the company's EBITDA has risen 18% a year on average.
The company generated cash, defined by a sum of net profit and depreciation, of CZK 374 mil or 7.55% of sales. When investments are excluded, free cash flow reached CZK 526 mil, or 10.6% of sales in 2016.
In the last five years, the company generated free cash flow of CZK 350 mil. That compares to a cumulative net profit of CZK 571 mil in the same period.
You can see all the company’s data at Roche Czech Republic profile, or you can download a report on the company in the report section.
Helgi Library 
